We are live on ! Find out more
BC

Bruce & Co Portfolio holdings

AUM $350M
1-Year Est. Return 33.5%
This Fund
S&P 500
This Quarter Est. Return
+11.07%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$500M
AUM Growth
+$29.5M
Cap. Flow
-$36.4M
Cap. Flow %
-7.28%
Top 10 Hldgs %
73.02%
Holding
31
New
Increased
1
Reduced
6
Closed

Top Buys

Rank Stock Value
1
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
+$474K

Sector Composition

Rank Sector Weight
1 Healthcare 38.91%
2 Utilities 28.57%
3 Industrials 12.91%
4 Financials 7.09%
5 Technology 5.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTRS icon
26
Viatris
VTRS
$20.1B
$832K 0.17%
61,512
FTK icon
27
Flotek Industries
FTK
$947M
$476K 0.1%
70,279
RLI icon
28
RLI Corp
RLI
$5.66B
$269K 0.05%
4,800

Similar funds

Bruce & Co's Q4 2021 Portfolio in Review

As of Q4 2021, Bruce & Co held 31 positions worth $500M, up 6.3% from $471M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Bruce & Co withdrew a net $36.4M in Q4 2021, reducing 6 holdings. Its largest reduction was Apple, cutting an estimated $11.9M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 37% a quarter earlier, followed by Utilities and Industrials.

Against the trend, Bruce & Co added an estimated $474K to Paratek Pharmaceuticals, Inc..

  • Bruce & Co added most to Paratek Pharmaceuticals, Inc. in Q4 2021, an estimated $474K increase.
  • Bruce & Co's biggest Q4 2021 reduction was Apple, cutting an estimated $11.9M.
  • Bruce & Co's ten largest holdings make up 73% of its $500M portfolio in Q4 2021.
  • Bruce & Co opened 0 new positions and closed 0 in Q4 2021.
  • Bruce & Co's portfolio value rose 6.3% quarter-over-quarter to $500M.

Based on Bruce & Co's 13F filing for Q4 2021, filed 16 Feb 2022.